Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Wednesday morning. The firm issued a hold rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $0.56 on Wednesday. The stock has a market capitalization of $42.82 million, a price-to-earnings ratio of -5.59 and a beta of 0.97. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.35. The stock’s 50-day moving average price is $0.66 and its 200-day moving average price is $0.70.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $2.26 million for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%.

Hedge Funds Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC purchased a new stake in Milestone Scientific Inc. (NYSE:MLSS) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 27,936 shares of the company’s stock, valued at approximately $26,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.